Early Achievable SeveritY (EASY) index for simple and accurate early risk stratification in acute pancreatitis

ISRCTN ISRCTN10525246
DOI https://doi.org/10.1186/ISRCTN10525246
Secondary identifying numbers N/A
Submission date
13/11/2014
Registration date
28/11/2014
Last edited
08/06/2022
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Digestive System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
Acute pancreatitis (AP) is a serious condition where the pancreas becomes inflamed over a short period of time. Assessing the severity is crucial to the management of the disease. Current methods of determining the level of risk (risk stratification) in AP have a limited value as they provide little additional information and thus may delay appropriate management. Early recognition of severe disease may prevent serious adverse events and improve patient management as well as overall clinical outcome. Our aim is to develop a simple, easy and accurate clinical scoring system that can stratify patients with AP during the first 6-12 hours of hospitalization according to their risk for severe disease course, and which can also be performed in small hospitals with limited access to diagnostic tools.

Who can participate?
Patients aged 18 to 99 hospitalized due to acute pancreatitis.

What does the study involve?
This is an observational study where information from the patients’ medical history, physical examination, laboratory tests and diagnostic imaging will be evaluated. The care or services that patients receive will not be altered by the study. All patients will be treated equally, according to the recently published guidelines.

What are the possible benefits and risks of participating?
Our goal is to develop a simple and accurate clinical scoring system for patient stratification. The ability to perform earlier and simpler risk stratification may prevent serious adverse events and improve patient management as well as overall clinical outcome. Because of the characteristics of the observation study there will be no risks of participation related to the trial.

Where is the study run from?
University of Szeged (Hungary)

When is the study starting and how long is it expected to run for?
December 2014 to May 2024 (updated 03/01/2020, previously: November 2017)

Who is funding the study?
Hungarian Pancreatic Study Group (HPSG) (Hungary).

Who is the main contact?
Balázs Kui, MD, PhD
k.kubali@gmail.com

Study website

Contact information

Dr Balázs Kui
Scientific

1st Department of Medicine
University of Szeged
Korányi fasor 8
Szeged
6720
Hungary

Email kubali@gmail.com

Study information

Study designObservational multicenter prospective cohort study
Primary study designObservational
Secondary study designCohort study
Study setting(s)Hospital
Study typeDiagnostic
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleEarly Achievable SeveritY (EASY) index for simple and accurate early risk stratification in acute pancreatitis: an observational multicenter prospective cohort study
Study acronymEASY
Study objectivesAcute pancreatitis is one of the most common diseases of the gastrointestinal tract that requires acute hospitalization and despite the special care is still associated with significant morbidity and mortality worldwide. The assessment of severity is a crucial issue in the management of acute pancreatitis. It is critical to identify patients who are at high risk for severe disease course, since they require close monitoring and immediate aggressive treatment.

Early recognition of severe acute pancreatitis by a simple, easy and accurate clinical scoring system for early prognostication of the disease may prevent serious adverse events and improve patient management as well as overall clinical outcome.
Ethics approval(s)The National Hungarian Ethical Authority (ETT TUKEB), No. 30595-1/2014/EKU
Health condition(s) or problem(s) studiedAcute pancreatitis
InterventionThe web-based Hungarian National Pancreas Registry would provide the background for data management of this trial. Simple attainable potential prognostic parameters from medical history, physical examination, laboratory tests and diagnostic imaging obtained at admission from patients diagnosed with acute pancreatitis will be evaluated to assess their potential correlation with the disease severity. The selected parameters that show the strongest correlation with severe disease course will be further utilized as potential early severity prognostic markers for prospective new patient stratification. The comparison of patients’ clinical course with the obtained results of early risk stratification in case of correlation may validate the utilized parameters as prognostic markers.
Intervention typeOther
Primary outcome measureValidation of previously selected parameters that showed the strongest correlation with severe disease course as prognostic markers to develop a simple, easy and accurate clinical scoring system that can stratify patients with acute pancreatitis during the first 6-12 hours of hospitalization according to their risk for severe disease course.
Secondary outcome measuresN/A
Overall study start date01/12/2014
Completion date31/05/2024

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
Upper age limit99 Years
SexBoth
Target number of participants1200
Total final enrolment1184
Key inclusion criteriaPatients (men and women aged 18 to 99 years) hospitalized due to acute pancreatitis diagnosed based on the fulfillment of two out of three of the criteria irrespectively of the etiology
Key exclusion criteriaN/A
Date of first enrolment01/12/2014
Date of final enrolment30/01/2024

Locations

Countries of recruitment

  • Hungary

Study participating centre

University of Szeged
1st Department of Medicine
Szeged
6720
Hungary

Sponsor information

Hungarian Pancreatic Study Group (HPSG)
Research organisation

Korányi fasor 8
Szeged
6720
Hungary

Email hpsg.info@gmail.com
Website http://www.pancreas.hu

Funders

Funder type

Research organisation

The Hungarian Pancreatic Study Group (HPSG)

No information available

Results and Publications

Intention to publish date31/05/2025
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planThe prestudy protocol was published in June 2015 in the Journal of Gastrointestinal and Liver Diseases:
http://jgld.ro/2015/2/12.pdf
IPD sharing planNot provided at time of registration

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Protocol article protocol 01/06/2015 Yes No
Results article 01/06/2022 08/06/2022 Yes No

Editorial Notes

08/06/2022: The following changes have been made:
1. Publication reference added.
2. The total final enrolment number has been added.
03/01/2020: The following changes were made to the trial record:
1. The recruitment end date was changed from 30/01/2019 to 30/01/2024.
2. The overall end date was changed from 31/05/2019 to 31/05/2024.
3. The intention to publish date was changed from 31/07/2019 to 31/05/2025.
4. The plain English summary was updated to reflect these changes.
19/02/2018: The overall trial end date has been updated from- 30/11/2017 to 31/05/2019. The recruitment end date has been updated from 30/11/2017 to 30/01/2019. Dr István Hritz 9istvan.hritz@freemail.hu) has been removed from the study contact and Balázs Kui, MD, PhD (k.kubali@gmail.com) has been added.